- Lung Cancer Basics
Washington, DC [March 3, 2009] – Today Congressman Henry Waxman (D-CA) reintroduced the Family Smoking Prevention and Tobacco Control Act (HR. 1256) to the 111th Congress. HR. 1256 is bipartisan legislation that would grant the US Food and Drug Administration (FDA) authority to regulate tobacco products.
The Family Smoking Prevention and Tobacco Control Act was originally introduced to the 110th Congress by Rep. Waxman in February of 2007 and passed the House with a vote 326-102 in July of 2008.
The Family Smoking Prevention and Tobacco Control Act amends the Federal Food, Drug and Cosmetic Act (FFDCA) to grant the Food and Drug Administration (FDA) the authority to regulate the sale, marketing and manufacturing of tobacco products.
Key features of the act are:
The passage of this legislation would set a new series of standards for tobacco regulation. Tobacco products would not be regulated under the “safe and effective” standard currently used for other products, but instead under a new standard of “appropriate for the protection of the public health.” This language would strengthen FDA’s regulatory ability under the FFDCA.
The Family Smoking Prevention and Tobacco Control Act has already received the support of over 900 public health, faith and other organizations from around the country. These include the American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, the Campaign for Tobacco-Free Kids, the President’s Cancer Panel and the Institute of Medicine.
Lung Cancer Alliance is in full support of The Family Smoking Prevention and Tobacco Control Act and will be monitoring the progress of this legislation as it moves forward. Please stay tuned to www.lungcanceralliance.org for regular updates.
To read The Family Smoking Prevention and Tobacco Control Act in its entirety, please click here.